Artemis Therapeutics, Inc. Contracts & Agreements
47 Contracts & Agreements
- Business Finance (28 contracts)
- Business Operations (5)
- Human Resources (7)
- Intellectual Property (2)
- Mergers & Acquisitions (1)
- Uncategorized (4)
- Description of Securities (Filed With SEC on March 31, 2023)
- Form of Indemnification Agreement (Filed With SEC on November 21, 2022)
- Personal Employment Agreement between Manuka Ltd. and Shimon Citron, dated April 13, 2022 (Filed With SEC on November 21, 2022)
- Form of Indemnification Agreement (Filed With SEC on September 21, 2022)
- Service Agreement, dated as of July 26, 2022, by and between the Company and David Dana (Filed With SEC on August 2, 2022)
- Certificate of Designation of Series D Convertible Preferred Stock (Filed With SEC on July 5, 2022)
- First Amendment to the Share Exchange Agreement by and between Artemis Therapeutics, Inc., Manuka Ltd., an Israeli company and the shareholders of Manuka Ltd., dated June 30, 2022 (Filed With SEC on July 5, 2022)
- Supply Agreement between Manuka Ltd. and Waitemata Honey Co. Ltd., dated July 20, 2021 (Filed With SEC on July 5, 2022)
- English Translation of Agreement between Manuka Ltd. and Chic Cosmetic Industries 1987 Ltd., dated December 14, 2021 (Filed With SEC on July 5, 2022)
- English Translation of Import License from the Israeli Ministry of Health, dated February 28, 2022 (Filed With SEC on July 5, 2022)
- Form of Warrant Exchange Agreement (Filed With SEC on July 5, 2022)
- Form of Debt Forgiveness Agreement (Filed With SEC on July 5, 2022)
- Share Exchange Agreement by and between Artemis Therapeutics, Inc., Manuka Ltd., an Israeli company and the shareholders of Manuka Ltd., dated March 6, 2022 (Filed With SEC on May 23, 2022)
- Description of Securities (Filed With SEC on March 3, 2022)
- Unsecured Promissory Note issued to KRNY Ltd (Filed With SEC on November 10, 2021)
- Unsecured Promissory Note issued to Harmony (H.A.) Investments Ltd (Filed With SEC on November 10, 2021)
- Form of Unsecured Promissory Note (Filed With SEC on August 19, 2019)
- First Amendment to Employment Agreement, dated January 3, 2018, between Brian M. Culley and Artemis Therapeutics, Inc (Filed With SEC on January 5, 2018)
- COMMON STOCK PURCHASE WARRANT ARTEMIS THERAPEUTICS, INC. (Filed With SEC on October 25, 2017)
- Exhibit 10.1 SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 25, 2017)
- Employment Agreement, executed as of August 9, 2017, between Brian Culley and Artemis Therapeutics, Inc (Filed With SEC on August 11, 2017)
- **Confidential portions have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission (the... (Filed With SEC on June 29, 2017)
- STOCK OPTION AGREEMENT (Filed With SEC on March 30, 2017)
- STOCK OPTION AGREEMENT (Filed With SEC on March 30, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on January 17, 2017)
- **Confidential portions have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission (the... (Filed With SEC on December 15, 2016)
- ARTEMIS THERAPEUTICS INC. Non-Qualified Stock Option Agreement (Filed With SEC on October 18, 2016)
- **Confidential portions have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission (the... (Filed With SEC on October 18, 2016)
- FIRST AMENDMENT TO THE LICENSE AGREEMENT (Filed With SEC on October 18, 2016)
- CONSULTING AGREEMENT (Filed With SEC on October 18, 2016)
- ARTEMIS THERAPEUTICS INC. NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on October 18, 2016)
- NEW YORK GLOBAL INNOVATIONS INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES B CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE... (Filed With SEC on August 29, 2016)
- NEW YORK GLOBAL INNOVATIONS INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE... (Filed With SEC on August 29, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 29, 2016)
- NEW YORK GLOBAL INNOVATIONS INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES B CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE... (Filed With SEC on August 3, 2016)
- NEW YORK GLOBAL INNOVATIONS INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE... (Filed With SEC on August 3, 2016)
- SECOND AMENDMENT TO SERIES A WARRANT (Filed With SEC on August 3, 2016)
- AGREEMENT AND PLAN OF MERGER BY AND AMONG NEW YORK GLOBAL INNOVATIONS INC., ARTEMIS ACQUISITION CORP. AND ARTEMIS THERAPEUTICS INC. AUGUST 2, 2016 TABLE OF CONTENTS (Filed With SEC on August 3, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 3, 2016)
- CONSULTING AGREEMENT (Filed With SEC on March 10, 2016)
- CONSULTING AGREEMENT (Filed With SEC on August 14, 2014)
- AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENT (Filed With SEC on March 6, 2014)
- AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT (Filed With SEC on January 14, 2014)
- ASSET PURCHASE AGREEMENT (Filed With SEC on October 3, 2013)
- STOCKHOLDER VOTING AGREEMENT (Filed With SEC on October 3, 2013)
- STOCK REPURCHASE AGREEMENT (Filed With SEC on September 6, 2011)
- STOCK REPURCHASE AGREEMENT (Filed With SEC on September 6, 2011)